TP53 and colorectal cancer: (b) Shortlisted predictive models of deficiency of BRCA1 or BRCA2; (c) TP53 monoallelic predictive models; (d) monoallelic gene deficiency models across colorectal cancer patients; and (e) remaining gene deficiency models not contained in the other sub-groups.